Search MalaCards:
MCID: PRS040

Prostate Cancer malady
55 drugs, 2483 genes, 37 tissues, 1467 related diseases, 29 phenotypes, 8552 articles, clinical trials.

Summaries for Prostate Cancer

about this section
Sources:
22MalaCards
See all sources

Export this MalaCard
MalaCards: Prostate Cancer, also known as prostatic neoplasms, is related to prostatitis and carcinoma. An important gene associated with Prostate Cancer is RNASEL (ribonuclease L (2',5'-oligoisoadenylate synthetase-dependent)), and among its related pathways are Pathways in cancer and GPCR Pathway. The drugs chlorotrianisene and hydroxyurea and the compounds dexamethasone and atp have been mentioned in the context of this disorder. Affiliated tissues include bone marrow, whole blood and lymph node, and related mouse phenotypes are homeostasis/metabolism and cellular.

Aliases & Descriptions for Prostate Cancer

about this section
Sources:
6Disease Ontology, 32Novoseek , 43UMLS, 33OMIM, 40SNOMED-CT, 24MeSH, 27NCIt
See all sources

Aliases & Descriptions:

prostate cancer 6
prostatic neoplasms 32 43
malignant tumor of prostate (disorder) 6
neoplasm of prostate (disorder) 6
malignant tumor of the prostate 6
malignant neoplasm of prostate 43
ngp - new growth of prostate 6
tumor of the prostate 6
malignant neoplasms 43
prostatic neoplasm 6
prostate neoplasm 6
prostatic cancer 6
neoplasms 43

Related Diseases for Prostate Cancer

about this section
Sources:
13GeneCards, 14GeneDecks
See all sources

Disease types for prostate cancer family:

prostate cancer 3 prostate cancer 4

Diseases related to prostate cancer by text searches and GeneDecks gene sharing:

(show top 50)    (show all 1462)
idRelated DiseaseScoreTop Affiliating Genes
1prostatitis509.5ZNF608, ZNF185, ZNF462, ZNF155, ZNF652, ZNF718
2carcinoma498.1ZNF608, PIK3CB, PIP, PIK3CD, PIM2, PIK3CA
3leukemia365.4PIK3CB, PIK3CD, PIM2, PIAS2, PIK3CA, PIK3R3
4neuronitis363.9ZNF462, PIK3CB, PIK3CD, PIK3CA, PIK3R3, PIK3R2
5adenocarcinoma345.2PIK3CB, PIP, PIM2, PIK3CA, PIK3R1, PI16
6pancreatitis336.5PIK3CB, PIK3CD, PIK3CA, PIK3R3, PIK3R2, PIK3R1
7melanoma298.2PIK3CB, PIK3CD, PIK3CA, PIK3R3, PIK3R2, PIK3R1
8hepatocellular carcinoma284.7PIK3CB, PIK3CD, PIM2, PIK3CA, PIK3R1, PIK3CG
9thyroiditis273.3PIK3CB, PIK3CA, PIK3R1, PIK3C2A, PIK3CG, PIN1
10gastric cancer273.1PIK3CB, PIK3CA, PIK3R1, PIAS1, PIK3CG, PIN1
11breast carcinoma242.1PIP, PIK3CA, PIK3R1, PIK3CG, NCL, NCOA2
12hypoxia241.9PIK3CB, PIK3CD, PIK3CA, PIK3R1, PIAS4, PIK3C2A
13cervicitis232.8PIK3CA, PIK3CG, PIN1, LRIG1, RFC1, NCL
14esophagitis232.0PIK3CB, PIK3CA, PIK3C2A, PIK3CG, PIN1, PIK3C3
15neuroblastoma221.9PIK3CB, PIK3CD, PIAS2, PIK3CA, PIK3R1, PIK3CG
16adenoma214.7PIK3CA, NCAM1, NCOA1, NCOA2, NCOA3, NCOR1
17alzheimer's disease210.5PIK3CB, PIK3CD, PIK3CA, PIK3R1, PIK3AP1, PIK3CG
18sarcoma206.2PIK3CB, PIK3CD, PIK3CA, PIK3R2, PIK3R1, PIK3C2B
19cholesterol197.4PIK3CB, PIK3CD, PIK3CA, PIK3R2, PIK3R1, PIK3C2B
20ovarian carcinoma192.0PIP, PIK3CA, PIP5K1A, PIK3CG, NCOA3, PDCD4
21myeloid leukemia192.0PIK3CB, PIK3CD, PIM2, PIK3CA, PIK3R3, PIK3R2
22myeloma188.1PIM2, PIK3CA, PIAS3, PIK3R2, PIK3R1, PIK3CG
23fibrosis186.2PIK3CA, PIAS3, PIK3CG, PIN1, KLF6, NCOA3
24retinitis185.5PIK3CA, PIK3C2A, PIK3CG, PIM1, LRAT, LRP2
25lung carcinoma177.1PIK3CA, PIK3R1, PIK3CG, LRP1B, KLF6, NCAM1
26cerebritis173.8PIK3R1, PIK3C2A, PIK3CG, LRP2, KLF6, NCAM1
27cervical cancer169.0PIK3CA, PIK3CG, PIN1, LRIG1, RFC1, NCL
28colon cancer167.9PIK3CB, PIAS2, PIK3CA, PIK3R3, PIK3R1, PIAS1
29obesity167.7PIK3CB, PIK3CA, PIK3R1, PIK3C2A, PIK3CG, LRP5
30atherosclerosis165.3PIK3C2A, PIK3CG, LRP2, LRP5, KLF10, KLF5
31osteosarcoma165.0PIK3CB, PIK3CA, PIK3CG, LRP5, KLF10, RFC1
32colon carcinoma162.9PIK3CB, PIK3CA, PIK3R2, PIK3R1, PIAS1, PIK3CG
33multiple myeloma157.7PIK3CA, PIAS3, PIK3R2, PIK3R1, PIK3CG, NCAM1
34lymphocytic leukemia154.6PIK3CD, PIM2, PIK3CA, PIK3CG, NCAM1, NCL
35diabetes mellitus150.8PIK3CB, PIK3CD, PIK3CA, PIK3R3, PIK3R2, PIK3R1
36astrocytoma150.4PIK3CA, PIK3R1, PIK3CG, KLF6, NCAM1, RECK
37acute myeloid leukemia143.1PIK3CB, PIK3CD, PIM2, PIK3CA, PIK3R3, PIK3R2
38retinoblastoma138.7PIK3CB, PIK3CD, PIK3CA, PIK3R1, PIK3CG, KLF6
39arthritis138.3PIK3CD, PIK3CG, PIN1, LRP2, LRP5, KLF5
40lymphoblastic leukemia137.8PIK3CA, PIK3CG, LRP5, KLF10, KLF5, RFC1
41epithelial ovarian cancer137.2PIK3CB, PIK3CA, PIK3R3, PIK3CG, NCOA1, NCOA3
42gonococcal synovitis135.5PIK3CB, PIK3CA, PIK3R1, PIK3CG, NCAM1, NCOA1
43nasopharyngitis131.8PIK3CA, PIK3CG, KLF5, KLF6, NCOA3, RECK
44nephropathy128.8LRP2, RELA, RETN, SGK1, CNDP2, KITLG
45rheumatoid arthritis127.2PIK3CD, PIK3CG, PIN1, LRP2, LRP5, KLF5
46peritonitis125.4PIK3C2A, REG4, RELA, RELB, RET, SGK1
47endometriosis124.1PIK3CA, NCOA1, NCOR1, NCOR2, RELA, CNTF
48insulin resistance123.0PIK3CB, PIK3CA, PIK3R2, PIK3R1, PIK3CG, RELA
49meningioma122.1PIK3CG, RFC1, NCAM1, NCL, NCOA2, NCOA3
50cervical carcinoma119.9PIK3CA, PIK3CG, RECK, RELA, CNR1, KIT

Graphical network of the top 20 diseases related to prostate cancer:



Graphical network of diseases related to prostate cancer

Clinical Features for Prostate Cancer

about this section

Drugs & Therapeutics for Prostate Cancer

about this section
Sources:
4CenterWatch, 29NIH Clinical Center, 5ClinicalTrials, 21LifeMap Discovery™, 43UMLS, 28NDF-RT
See all sources

Approved drugs:

Search CenterWatch for prostate cancer

Drug clinical trials:

Search ClinicalTrials for prostate cancer

Search NIH Clinical Center for prostate cancer

Search CenterWatch for prostate cancer

Inferred drug relations via UMLS/NDF-RT:

43 28 aminoglutethimide, bicalutamide, chlorotrianisene, cisplatin, cisplatin pwdr [va product], dexamethasone, dexamethasone acetate, dexamethasone acetate pwdr [va product], dexamethasone phosphate, dexamethasone sodium phosphate, dexamethasone sodium phosphate pwdr [va product], diethylstilbestrol, diethylstilbestrol diphosphate, doxorubicin hydrochloride, estradiol, estradiol 17-beta, estradiol acetate, estradiol cypionate, estradiol pwdr [va product], estradiol valerate, estramustine, estramustine phosphate sodium, estrogens, estrogens,conjugated, estrogens,conjugated synthetic a, estrogens,conjugated synthetic b, estrogens,esterified, estrone, estrone sodium sulfate, ethinyl estradiol, etoposide, etoposide phosphate, finasteride, flutamide, goserelin acetate, hydroxyurea, leuprolide, leuprolide acetate, linolenic acid, methylprednisolone, methylprednisolone acetate, methylprednisolone sodium succinate, mitoxantrone, mitoxantrone hydrochloride, nilutamide, polyestradiol, polyestradiol phosphate, prednisolone, prednisolone acetate, prednisolone acetate pwdr [va product], prednisolone pwdr [va product], prednisolone sodium phosphate, prednisolone tebutate, prednisone, prednisone pwdr [va product]

Cell-based therapeutics:


LifeMap Discovery
The database of embryonic development, stem cell research and regenerative medicine
Stem-Cell-Based therapeutic approaches for prostate cancer:
Alescat - autologous lymphocyte -based therapy for the treatment of solid cancers

Genetic Tests for Prostate Cancer

about this section

Anatomical Context for Prostate Cancer

about this section
Sources:
22MalaCards
See all sources

MalaCards organs/tissues related to prostate cancer:

22
Bone marrow, Whole blood, Lymph node, Brain, Heart, Small intestine, Colon, Adipocyte, Kidney, Liver, Lung, Pancreas, Thyroid, Salivary gland, Adrenal gland, Breast, Skin, Ovary, Placenta, Prostate, Testis, Cervix, Myeloid, Monocytes, Nk cells, T cells, B cells, Endothelial, Fetal brain, Pons, Tongue, Fetal liver, Fetal lung, Fetal thyroid, Pineal, Pituitary, Testis germ

Phenotypes for genes affiliated with Prostate Cancer

about this section
Sources:
25MGI
See all sources

MGI Mouse Phenotypes related to prostate cancer:

25 (show all 29)
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1homeostasis/metabolism phenotypeMP:0005376185.7PIK3CB, PIK3CD, PIK3CA, PIK3R2, PIK3R1, PIK3C2A
2cellular phenotypeMP:0005384173.1PIK3CB, PIK3CD, PIM2, PIK3CA, PIK3R1, PIK3AP1
3mortality/agingMP:0010768169.5PIK3CB, PIK3CA, PIP5K1A, PIAS4, PIAS1, PIK3C2A
4growth/size phenotypeMP:0005378158.1PIK3CB, PIM2, PIK3CA, PIK3R1, PIAS1, PIK3C2A
5cardiovascular system phenotypeMP:0005385131.3PIK3CB, PIK3CD, PIK3CA, PIK3R2, PIK3R1, PIK3CG
6immune system phenotypeMP:0005387115.9PIK3CD, PIM2, PIK3AP1, PIAS4, PIAS1, PIK3R5
7nervous system phenotypeMP:0003631111.8WDR19, LRIG1, LRAT, LRP5, NCK1, NCOA1
8behavior/neurological phenotypeMP:0005386108.3PIK3CA, PIK3C3, LRP2, LRP5, RFX6, NCAM1
9hematopoietic system phenotypeMP:000539788.2PIM2, PIK3AP1, PIP5K1A, PIAS4, PIM1, KLF6
10reproductive system phenotypeMP:000538987.0PIK3CA, PIP5K1A, LRAT, KLF6, NCOA1, NCOA2
11integument phenotypeMP:001077186.6PIK3C2B, PIK3CG, PIN1, LRIG1, KLF10, KLF6
12normal phenotypeMP:000287385.9PIAS2, PIK3R1, PIP5K1A, PIK3C3, LRIG1, LRP1B
13muscle phenotypeMP:000536985.4PIK3CA, PIK3R2, PIK3R1, PIK3CG, PIK3C3, WDR19
14tumorigenesisMP:000200681.9PIK3CB, PIK3CA, PIK3R2, PIK3R1, LRIG1, KLF10
15digestive/alimentary phenotypeMP:000538181.6WDR19, LRIG1, LRP2, KLF5, RFX6, NCOA3
16embryogenesis phenotypeMP:000538078.3PIK3CB, PIK3CA, PIK3C3, WDR19, LRP5, KLF5
17vision/eye phenotypeMP:000539176.2PIK3CA, PIN1, WDR19, LRAT, LRP2, LRP5
18skeleton phenotypeMP:000539075.3PIK3CD, PIK3CG, WDR19, LRP2, KLF10, NCOA1
19renal/urinary system phenotypeMP:000536759.0LRP2, NCK1, NCOA1, NCOA3, PDC, PDCD4
20limbs/digits/tail phenotypeMP:000537151.4WDR19, LRIG1, LRP5, KLF10, RECK, RELA
21endocrine/exocrine gland phenotypeMP:000537950.6PIP5K1A, LRIG1, LRP2, LRP5, KLF5, RFX6
22no phenotypic analysisMP:000301250.3PIK3CD, PIK3R1, PIK3C2B, LRP2, NCOA2, RET
23liver/biliary system phenotypeMP:000537050.1PIK3C3, LRP5, KLF6, NCOA3, NCOR1, NCOR2
24adipose tissue phenotypeMP:000537548.8PIK3CA, PIK3R1, PIK3C2A, NCOA3, NCOR1, NCOR2
25craniofacial phenotypeMP:000538244.6WDR19, LRIG1, LRP2, LRP5, NCOA3, NCOR2
26hearing/vestibular/ear phenotypeMP:000537741.2WDR19, LRP2, NCOA3, KIT, KITLG, RDX
27respiratory system phenotypeMP:000538837.5LRP2, KLF5, REL, RELB, RET, KIFAP3
28pigmentation phenotypeMP:000118628.8LRP5, KIT, KITLG, RB1, SEMA3C, SERPINC1
29other phenotypeMP:000539526.4RECK, RELB, CNR1, VASP, RARA, RARB

Publications for genes affiliated with Prostate Cancer

about this section
Sources:
35PubMed
See all sources

Articles related to prostate cancer:

(show top 50)    (show all 8552)
idTitleAuthorsYearAffiliating Genes
1Association of short tandem repeat polymorphism in th e promoter of prostate cancer antigen 3 gene with the risk of prostate cancer. (21655300)Zhou W.... Tao Z.2011PCA3
2Expression of SLCO transport genes in castration-resi stant prostate cancer and impact of genetic variation in SLCO1B3 and SLCO2B1 on prostate cancer outcomes. (21266523)Wright J.L.... Mostaghel E.A.2011SLCO2B1, SLCO1B3
3LRIG1 and the liar paradox in prostate cancer: a stud y of the expression and clinical significance of LRIG1 in prostate cancer. (21128282)Thomasson M.... Hedman H.2011LRIG1
4Quantitative proteomic profiling of prostate cancer r eveals a role for miR-128 in prostate cancer. (19955085)Khan A.P.... Sreekumar A.2010MIR128-1
5Kisspeptin is released from human prostate cancer cel l lines but plasma kisspeptin is not elevated in patients with prostate cancer. (20428832)Curtis A.E.... Dhillo W.S.2010KISS1
6Performance of prostate cancer antigen 3 (PCA3) and p rostate-specific antigen in Prescreened men: reproducibility and detection char acteristics for prostate cancer patients with high PCA3 scores (a8Y 100). (20933321)Roobol M.J.... van Leeuwen P.J.2010KLK3, PCA3
7Androgen receptor CAG repeat length and association w ith prostate cancer risk: results from the prostate cancer prevention trial. (20952028)Price D.K.... Figg W.D.2010AR
8Selenite triggers rapid transcriptional activation of p53, and p53-mediated apoptosis in prostate cancer cells: Implication for the treatment of early-stage prostate cancer. (20428765)Sarveswaran S.... Ghosh J.2010TP53
9Incidence of prostate cancer in male breast cancer patients: a risk factor for prostate cancer screening. (18504455)Lee U.J.... Jones J.S.2009ERBB2, ESR1
10LEF1 in androgen-independent prostate cancer: regulation of androgen receptor expression, prostate cancer growth, and invasion. (19351848)Li Y.... Lee P.2009AR, LEF1
11Fascin regulates prostate cancer cell invasion and is associated with metastasis and biochemical failure in prostate cancer. (19228738)Darnel A.D.... Bismar T.A.2009FSCN1
12Cystatin C is downregulated in prostate cancer and mo dulates invasion of prostate cancer cells via MAPK/Erk and androgen receptor pa thways. (19956729)Wegiel B.... Bjartell A.2009MMP2, CRP, CST3
13Prostate cancer antigen-1 contributes to cell survival and invasion though discoidin receptor 1 in human prostate cancer. (17970783)Shimada K.... Konishi N.2008BCL2L1, DDR1, CYCS
145alpha-androstane-3alpha,17beta-diol supports human prostate cancer cell survival and proliferation through androgen receptor-independent signaling pathways: implication of androgen-independent prostate cancer progression. (18320593)Yang Q.... Lin H.K.2008AR, CTNNB1, AKR1C4
15Adiponectin as a potential marker of prostate cancer progression: studies in organ-confined and locally advanced prostate cancer. (17465703)Housa D.... Haluzik M.2008ADIPOQ
16Further evidence for null association of phenol sulfotransferase SULT1A1 polymorphism with prostate cancer risk: a case-control study of familial prostate cancer in a Japanese population. (18368507)Koike H.... Suzuki K.2008SULT1A1
17Pathogenesis of prostate cancer and hormone refractor y prostate cancer. (19675761)Girling J.S.... Neal D.E.2007AR
18Detection of novel amplicons in prostate cancer by comprehensive genomic profiling of prostate cancer cell lines using oligonucleotide-based arrayCGH. (17712417)Kamradt J.... Wullich B.2007IL11RA, DCTN3
19Glutathione peroxidase 3, deleted or methylated in prostate cancer, suppresses prostate cancer growth and metastasis. (17804715)Yu Y.P.... Luo J.H.2007MET, GPX3
20ERRgamma suppresses cell proliferation and tumor growth of androgen-sensitive and androgen-insensitive prostate cancer cells and its implication as a therapeutic target for prostate cancer. (17510420)Yu S.... Chan F.L.2007CDKN1B, ESRRB
21CYP17 genetic variation and risk of breast and prostate cancer from the National Cancer Institute Breast and Prostate Cancer Cohort Consortium (BPC3). (18006912)Setiawan V.W.... Chanock S.J.2007CYP17A1
22A differential ligand-mediated response of green fluorescent protein-tagged androgen receptor in living prostate cancer and non-prostate cancer cell lines. (17312014)Nakauchi H.... Kawata M.2007AR
23Overexpression of cysteinyl LT1 receptor in prostate cancer and CysLT1R antagonist inhibits prostate cancer cell growth through apoptosis. (17549353)Matsuyama M.... Yoshimura R.2007ALOX5, CYSLTR1
24Sequence variants of estrogen receptor beta and risk of prostate cancer in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium. (17932344)Chen Y.C.... Weinstein S.J.2007ESR2
25Murine cell lines derived from Pten null prostate cancer show the critical role of PTEN in hormone refractory prostate cancer development. (17616663)Jiao J.... Wu H.2007PTEN
26Prostate cancer cells increase androgen sensitivity by increase in nuclear androgen receptor and androgen receptor coactivators; a possible mechanism of hormone-resistance of prostate cancer cells. (17364555)Fujimoto N.... Matsumoto T.2007AR, NCOA2, TGFB1I1
27Identification of genes linked to gefitinib treatment in prostate cancer cell lines with or without resistance to androgen: a clue to application of gefitinib to hormone-resistant prostate cancer. (16685379)Yano S.... Naito K.2006SFN, GARS, DUSP9
28Prostate derived factor in human prostate cancer cells: gene induction by vitamin D via a p53-dependent mechanism and inhibition of prostate cancer cell growth. (16741990)Lambert J.R.... Lucia M.S.2006TP53, GDF15
29A germ line mutation that delays prostate cancer progression and prolongs survival in a murine prostate cancer model. (15870705)Majeed N.... Pollak M.2005IGF1, GHRHR
30Silencing of polo-like kinase (Plk) 1 via siRNA causes induction of apoptosis and impairment of mitosis machinery in human prostate cancer cells: implications for the treatment of prostate cancer. (15661849)Reagan-Shaw S.... Ahmad N.2005PLK1
31New epitope peptides derived from parathyroid hormone-related protein which have the capacity to induce prostate cancer-reactive cytotoxic T lymphocytes in HLA-A2+ prostate cancer patients. (15389794)Yao A.... Itoh K.2005PTHLH
32Elevation of dipeptidylpeptidase iv activities in the prostate peripheral zone and prostatic secretions of men with prostate cancer: possible prostate cancer disease marker. (16094078)Wilson M.J.... Wasserman N.F.2005DPP4
33Identification of metastasis-associated genes in prostate cancer by genetic profiling of human prostate cancer cell lines. (15816537)Trojan L.... Michel M.S.2005SOCS2, DSG2, IL32
34Prostate cancer in patients with screening serum prostate specific antigen values less than 4.0 ng/dl: results from the cooperative prostate cancer tissue resource. (15821483)Datta M.W.... Berman J.J.2005KLK3
35Expression of the disintegrin metalloprotease, ADAM-10, in prostate cancer and its regulation by dihydrotestosterone, insulin-like growth factor I, and epidermal growth factor in the prostate cancer cell model LNCaP. (14734484)McCulloch D.R.... Odorico D.M.2004EGF, IGF1, ADAM10
36Prostate stem cell antigen (PSCA) expression in human prostate cancer tissues and its potential role in prostate carcinogenesis and progression of prostate cancer. (15132743)Zhigang Z.... Wenlv S.2004PSCA
37New targets for therapy in prostate cancer: differential display code 3 (DD3(PCA3)), a highly prostate cancer-specific gene. (14607216)Schalken J.A.... Verhaegh G.2003PCA3
38Mutations in ribonuclease L gene do not occur at a greater frequency in patients with familial prostate cancer compared with patients with sporadic prostate cancer. (15040862)Downing S.R.... Kantoff P.W.2003RNASEL
39Expressions of MAD2 and p55CDC in prostate cancer and their correlations with the prostate cancer grading (14710249)Xu K.... Hou S.2003MAD2L1, CDC20
40Genome-wide scan for prostate cancer susceptibility genes using families from the University of Michigan prostate cancer genetics project finds evidence for linkage on chromosome 17 near BRCA1. (14601029)Lange E.M.... Cooney K.A.2003MSR1, RNASEL, ELAC2
41Factors associated with initial therapy for clinically localized prostate cancer: prostate cancer outcomes study. (11752011)Harlan L.C.... Stephenson R.A.2001KLK3
42Concentration of enzymatically active prostate-specific antigen (PSA) in the extracellular fluid of primary human prostate cancers and human prostate cancer xenograft models. (11391681)Denmeade S.R.... Isaacs J.T.2001KLK3
43Predictive value of prostate specific antigen density in the detection of prostate cancer in patients with elevated prostate specific antigen levels and normal digital rectal findings or stage A prostate cancer (11329957)Iwaki H.... Yamauchi T.2001KLK3
44Antibody immunity to prostate cancer associated antigens can be detected in the serum of patients with prostate cancer. (11025777)McNeel D.G.... Disis M.L.2000KLK3
45NGF-beta, NE-cells and prostatic cancer cell lines. A study of neuroendocrine expression in the human prostatic cancer cell lines DU-145, PC-3, LNCaP, and TSU-pr1 following stimulation of the nerve growth factor-beta. (9561567)Angelsen A.... Waldum H.L.1998NGF
46Several genes encoding ribosomal proteins are over-expressed in prostate-cancer cell lines: confirmation of L7a and L37 over-expression in prostate-cancer tissue samples. (9724090)Vaarala M.H.... Vihko P.T.1998RPL4
47Detection of micrometastatic prostate cancer cells in the bone marrow of patients with prostate cancer. (9043017)Deguchi T.... Kawada Y.1997KLK3
48Estramustine phosphate versus placebo as second line treatment after orchiectomy in patients with metastatic prostate cancer: DAPROC A study 9002. Danish Prostatic Cancer Group. (9072602)Iversen P.... Rosenkilde P.1997KLK3
49Steroid-growth factor interaction in human prostate cancer. 2. Effects of transforming growth factors on androgen metabolism of prostate cancer cells. (8789735)Carruba G.... Castagnetta L.A.1996TGFA, TGIF1
50The benefit and cost of prostate cancer early detection. The Investigators of the American Cancer Society-National Prostate Cancer Detection Project. (7683964)Littrup P.J.... Mettlin C.J.1993KLK3

Expression for genes affiliated with Prostate Cancer

about this section
Sources:
1BioGPS
See all sources
Expression patterns in normal tissues for genes affiliated with Prostate Cancer

Pathways for genes affiliated with Prostate Cancer

about this section
Sources:
20KEGG, 36QIAGEN, 37R&D Systems, 3Cell Signaling Technology, 41Thomson Reuters, 10EMD Millipore
See all sources

Pathways related to prostate cancer according to GeneDecks:

(show top 50)    (show all 409)
idPathwayScoreTop Affiliating Genes
1Pathways in cancer2048.8PIK3CB, PIK3CD, PIAS2, PIK3CA, PIK3R3, PIAS3
2GPCR Pathway3641.3PIK3R3, PIK3R2, PIK3R1, KIT, KITLG, BTC
3MAPK Family Pathway3640.3PIK3R3, PIK3R2, PIK3R1, KITLG, BTC, SEMA3A
4Activation of PKA through GPCR3634.9KIT, KITLG, BTC, SEMA3A, BRAF, VEGFC
5Mitochondrial Apoptosis3633.1PIK3R3, PIK3R2, PIK3R1, KIT, KITLG, BTC
6STAT3 Pathway3631.8PIP, PIM1, BRAF, MYC, BMP10, BMP2
7DHA Signaling3631.7PIK3R3, PIK3R2, PIK3R1, KIT, KITLG, BTC
8TGF-beta Signaling Pathways3725.9PIK3CB, PIK3CD, PIK3R2, PIK3R1, PIK3C2B, PIK3CG
9Influenza A2025.9PIK3CB, PIK3CD, PIK3CA, PIK3R3, PIK3R2, PIK3R1
10Glioma Invasiveness3623.2PIK3R3, PIK3R2, KITLG, VTN, BTC, SEMA3A
11Jak-STAT signaling pathway2023.1PIK3CB, PIK3CD, PIAS2, PIK3CA, PIK3R3, PIAS3
12CDC42 Pathway3623.1KIT, LMTK2, MYLK, RAF1, RALA, LIMK1
13Cytoskeletal Signaling322.3NCK1, RDX, SEC23A, VIM, VCL, VCP
14EGF Pathway3621.7PIK3R3, PIK3R2, PIK3R1, NCK1, BRAF, VAV3
15Angiogenesis321.6RECK, SERPINB5, VHL, VEGFC, KDR, MST1R
16Toll-like receptor signaling pathway2021.6PIK3CB, PIK3CD, PIK3CA, PIK3R3, PIK3R2, PIK3R1
17Actin Nucleation and Branching3621.5KIT, LMTK2, RAC3, RAC1, RAC2, LIMK1
18SOCS Pathway3621.5VEGFC, BMP10, BMP2, BMP3, BMP4, BMP5
19TNF Superfamily Pathway3620.4PIK3R3, PIK3R2, PIK3R1, CHUK, JUN, FOS
20p53 Signaling3620.2PIAS1, SFN, BRCA1, BCL2, CHEK1, CHEK2
21PI3K Signaling in B-Lymphocyte3620.1PIK3R3, PIK3R1, PIK3C2B, PIK3AP1, PIK3C2A, PIK3C3
2214-3-3 Induced Apoptosis3620.0PIK3R3, PIK3R2, PIK3R1, MYD88, BID, BCL2
23PDGF Pathway3620.0PIK3R3, PIK3R2, PIK3R1, RAF1, RAC1, PAK4
24Development_Thrombopoietin-regulated cell processes4118.6PIK3CB, PIK3CD, PIK3CA, PIK3R3, PIK3R2, PIK3R1
25PGC1Alpha Pathway3618.4BMP10, BMP2, BMP3, BMP4, BMP5, BMP6
26Development Flt3 signaling1018.4PIK3CB, PIK3CD, PIK3CA, PIK3R2, PIK3R1, RAF1
27BAD Phosphorylation3617.9PIK3CD, PIK3R3, RAF1, BCL2, BCL2L1, YWHAB
28Development_PDGF signaling via STATs and NF-kB4117.7PIK3CB, PIK3CD, PIK3CA, PIK3R3, PIK3R2, PIK3R1
29Immune response IL-1 signaling pathway1017.6RELA, SERPINE1, MYD88, CHUK, UBE2V1, ATF2
30Translation _Regulation of EIF4F activity4117.5PIK3CB, PIK3CA, PIK3R3, PIK3R2, PIK3R1, RAC1
31Development_Flt3 signaling4117.3PIK3CB, PIK3CD, PIK3CA, PIK3R2, PIK3R1, RAC1
32Immune response CD16 signaling in NK cells1017.0PIK3CB, PIK3CD, PIK3CA, PIK3R3, PIK3R2, PIK3R1
33Adhesion316.8NCAM1, VCL, RAP1A, MTDH, CEACAM1, JUP
34SUMO Pathway3616.8PIAS1, RAN, CHUK, UBE2I, ATF4, IL1A
35Development EPO-induced Jak-STAT pathway1016.6PIM1, MYC, RAF1, BCL2, BCL2L1, CISH
36Immune response IL-3 activation and signaling pathway1016.6PIM1, RAF1, CISH, ATF2, JUN, JUNB
37Development_Growth hormone signaling via PI3K/AKT and MAPK cascades4116.4PIK3R1, CEBPB, ATF2, JUN, JUNB, JAK2
38Development CNTF receptor signaling1016.2PIK3CB, PIK3CD, PIK3CA, PIK3R3, PIK3R2, PIK3R1
39Thrombopoietin Pathway3616.2PIK3R3, PIK3R2, PIK3R1, RAF1, JUN, JAK2
40Translation _Regulation of EIF2 activity4116.0PIK3CB, PIK3CA, PIK3R3, PIK3R2, PIK3R1, RAF1
41Apoptosis and survival_Caspase cascade4115.9BID, PARP1, BAX, XIAP, IRS1, APAF1
42Development_CNTF receptor signaling4115.8PIK3CB, PIK3CD, PIK3CA, PIK3R2, PIK3R1, CNTF
43Development A2B receptor- action via G-protein alpha s1015.7PIK3CB, PIK3CD, PIK3CA, REL, RELA, RELB
44Cytoskeleton remodeling FAK signaling1015.7PIK3CB, PIK3CD, PIK3R3, PIK3R2, RAP1A, RAF1
45Apoptosis and survival Caspase cascade1015.6BID, PARP1, BAX, XIAP, IRS1, APAF1
46Common Cytokine Receptor Gamma-Chain Family Signaling Pathways3715.5PIK3CB, PIK3CD, PIK3R1, PIK3CG, BRAF, RAF1
47Development Leptin signaling via PI3K-dependent pathway1015.3PIK3CB, PIK3CD, PIK3CA, PIK3R2, PIK3R1, KCNJ11
48Translation Insulin regulation of translation1014.3PIK3CB, PIK3CD, PIK3R3, PIK3R2, PIK3R1, RAF1
49Signal transduction AKT signaling1013.9PIK3CB, PIK3CD, PIK3R3, PIK3R2, PIK3R1, REL
50Development FGF-family signaling1013.7PIK3CB, PIK3CD, PIK3R2, PIK3R1, FRS2, ITPR1

Compounds for genes affiliated with Prostate Cancer

about this section
Sources:
32Novoseek , 42Tocris Bioscience, 34PharmGKB, 9DrugBank, 18HMDB
See all sources

Compounds related to prostate cancer according to GeneDecks:

(show top 50)    (show all 436)
idCompoundScoreTop Affiliating Genes
1dexamethasone32 42 34 9 9 99.0PIK3CA, PIK3R1, NCAM1, NCOA2, REL, RETN
2atp32 81.7PIK3CB, PIK3CA, PIK3C2A, PIM1, LRAT, RFC1
3progesterone32 42 9 18 9 77.4PIP, PIK3CA, PIK3R1, PIAS1, LRAT, NCAM1
4cholesterol32 9 18 9 70.0PIK3CB, PIK3CA, PIK3R1, PIK3C2A, LRAT, LRP2
5paclitaxel32 34 9 9 58.4PIK3CA, PIK3CG, PIN1, NCL, KIT, KITLG
6glucose32 47.8CNTF, KIT, KISS1, BTC, SETD2, SERPINA2
7creatinine32 47.4NCAM1, RETN, SGCA, SGK1, KITLG, VWF
8hydrogen32 18 44.5PIN1, PIM1, SGCB, CNR2, SERPINB2, BRCA1
9gtp32 35.7PIK3CA, PIK3R1, PIK3C2A, PDC, RECK, SGCB
10acetylcholine32 9 18 9 38.7PIK3C2A, NCAM1, SGCB, CNR1, CNTF, VWF
11magnesium32 9 18 9 35.3PIK3C2B, PIK3C2A, LRP2, GC, MYLK, BMPR1A
12camptothecin32 42 9 9 34.4PIK3CG, NCL, PCNA, RB1, NBN, SETD2
13potassium32 9 18 9 34.2PIK3CA, PIK3C2A, NCAM1, SGCB, SGK1, CNGB1
14mg 13232 42 31.6PIK3CG, NCOA2, NCOR2, PCNA, BRCA1, VDR
15bromodeoxyuridine32 30.2PIK3CA, PIK3R1, NCAM1, NCOA3, CNTF, KITLG
16gf 109203x32 42 29.0PIK3CB, PIK3CG, KITLG, VEGFA, VCL, RAP1A
17cytarabine32 34 9 9 27.1KIT, KITLG, PCNA, RB1, VIM, MYC
18gdp32 23.6PDC, KIFAP3, RDX, VIM, RAP1A, RAD51
19adenine32 9 18 9 26.6RET, VWF, SETD2, NAT1, NAT2, BRAF
20pdtc32 23.3PIK3CA, PIK3CG, SELE, SETD2, SERPINB5, VCAM1
21hyaluronic acid32 18 24.0VTN, RDX, VIM, VCAN, MYC, BMP6
22sphingosine32 9 18 9 24.1PIK3R1, VIM, LPAR3, VCAM1, RASA2, PAK2
23trastuzumab32 34 9 9 24.0PIK3CA, PIK3R1, PIK3CG, KIT, VEGFC, RAF1
24progestins32 20.9PIP, LIF, S100A6, JAK2, MMP3, MKI67
25homocysteine32 18 21.5PIK3C2A, RETN, VWF, SELE, SELP, SERPINC1
26sodium dodecylsulfate32 20.4VWF, VTN, SERPINB6, SERPINF2, SERPINE1, LPL
27cocaine32 9 9 22.4PIK3C2A, CNR1, CNTF, SELE, SELP, VIM
28hydroxyurea32 9 9 22.2NCL, KIT, KITLG, PCNA, NBN, BRCA1
29daunorubicin32 9 9 21.9RELA, KITLG, MYC, RAF1, RALBP1, BIRC5
30leukotriene b432 42 18 21.1GC, SELP, RAC1, LCN2, MPO, MMP9
31chondroitin sulfate32 18 20.0NCAM1, VTN, GC, VIM, VCAN, BMP6
323-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide32 18.4PCNA, MYC, PARP1, BCL2, BCL2L1, BAK1
33peroxynitrite32 18.3SGCB, SERPINA1, SEPP1, NAT1, PARP1, KCNMA1
34sodium orthovanadate32 17.9SETD2, VCL, RAF1, BLZF1, BCR, JAK2
35ifn-alpha32 17.9LIF, CISH, JAK1, CDK2, CDKN2A, IRF1
3617-(allylamino)-17-demethoxygeldanamycin32 17.8KIT, SETD2, BRAF, RAF1, BIRC5, CHEK1
37lithium32 34 9 18 9 21.8PIK3R1, BDNF, SCG2, MUC1, XBP1, CDK5
38androstane32 17.7NCOA1, NCOA2, VDR, UGT1A, UGT1A1, GSTA1
39rotenone32 17.6PIK3CG, PARP1, PARK7, BCL2, BCL2L1, UCP1
4017beta-hydroxysteroid32 17.3BRCA1, S100A6, CGA, CGB5, MKI67, AR
41eb 108932 17.2PCNA, VDR, CLU, BGLAP, PARP1, BCL2
42cytosine32 18 18.1RELN, SERPINB5, SERPINB2, BRCA1, RAD51, RASSF1
43fluvastatin32 34 9 9 20.0PIK3C2A, VWF, SELP, SERPINE1, LPL, VCAM1
44bapta32 16.1SETD2, RAF1, S100A6, P2RY2, FOS, MAPK3
45bisindolylmaleimide32 16.1PIK3CB, RAF1, RAC1, BDNF, S100B, CFLAR
46tpck32 15.9PIK3CG, PARP1, BCL2L1, BAK1, JUN, IL1B
4725-hydroxyvitamin d32 15.9SFRP4, GC, SEC14L2, VDR, BGLAP, PAX5
48s-nitroso-n-acetylpenicillamine32 15.8SGCB, PARP1, XDH, FN1, IL1B, IL8
49vitamin b1232 15.2LRP2, VWF, PCNA, SERPINA3, MUT, MTRR
50neopterin32 15.1PAH, LGALS3BP, CHIT1, LCN2, B2M, CD14

GO Terms for genes affiliated with Prostate Cancer

about this section
Sources:
12Gene Ontology
See all sources

Cellular components related to prostate cancer according to GeneDecks:

(show all 16)
idNameGO IDScoreTop Affiliating Genes
1nucleusGO:005634154.8ZNF462, ZNF155, ZNF652, ZNF718, PIK3CB, PIAS2
2cytoplasmGO:005737141.8ZNF185, PIAS3, PIP5K1A, PIAS4, PIK3R5, PIK3C2A
3plasma membraneGO:005886108.4PIK3CD, PIK3R1, PIK3C2B, PIK3AP1, PIP5K1A, PIK3C2A
4cytosolGO:005829106.8PIK3CB, PIK3CD, PIK3CA, PIK3R3, PIK3R2, PIK3R1
5extracellular regionGO:00557670.4PIP, PI16, NCAM1, REG4, RETN, KISS1
6nucleoplasmGO:00565460.1PIAS1, PIN1, RFC1, NCOA1, NCOA2, NCOA3
7extracellular spaceGO:00561558.7LRP2, RELN, CNTF, KIT, KITLG, VTN
8integral to plasma membraneGO:00588754.9RET, SGCB, CNR1, CNR2, SELP, VIPR1
9nucleolusGO:00573052.9PIP5K1A, PIAS4, KLF5, KLHL20, NCL, NCOA3
10membraneGO:01602032.5PIK3R5, PIK3CG, RECK, GCNT2, SEMA3C, SERPINA5
11cell surfaceGO:00998632.5KLHL20, NCAM1, SFRP1, SFRP4, VEGFA, LPAR1
12perinuclear region of cytoplasmGO:04847132.0LRAT, KLHL20, KIF5B, GC, SELE, SERBP1
13external side of plasma membraneGO:00989720.0NCAM1, KIT, VWF, SELP, SERPINA5, VCAM1
14membrane raftGO:04512118.3SGCA, SELE, BSG, RAB5A, PAG1, BCL10
15caveolaGO:00590115.6SELE, BMPR1A, BMPR2, LIPE, KCNMA1, SCARB1
16platelet alpha granule lumenGO:03109315.3VWF, SERPINF2, SERPINA1, SERPINE1, VEGFA, VEGFC

Biological processes related to prostate cancer according to GeneDecks:

(show top 50)    (show all 99)
idNameGO IDScoreTop Affiliating Genes
1signal transductionGO:00716559.6PIK3CB, PIK3CD, PIP5K1A, PDE11A, RET, CNTF
2small molecule metabolic processGO:04428157.0PIK3CB, PIK3CD, PIK3CA, PIK3R3, PIK3R2, PIK3R1
3apoptotic processGO:00691550.2PIM1, PDCD4, PDCD5, SGK1, SFN, PCNT
4positive regulation of transcription, DNA-dependentGO:04589344.8PIM2, PIAS2, PIAS1, LRP5, KLF5, KLF6
5negative regulation of cell proliferationGO:00828540.8PIM2, KLF10, KIFAP3, SFN, SFRP1, SFRP4
6negative regulation of transcription from RNA polymerase II promoterGO:00012239.3PIAS4, KLF10, NCOA2, NCOR1, NCOR2, PCGF2
7negative regulation of transcription, DNA-dependentGO:04589235.2PIAS4, PDCD4, RELA, SFRP1, BTRC, RB1
8gene expressionGO:01046732.5NCOR1, NCOR2, PCBP1, PCBP2, RBL1, SET
9innate immune responseGO:04508731.0PIK3CD, PIK3CG, PIN1, PIK3C3, RELA, PCBP2
10protein phosphorylationGO:00646830.4PIK3CD, PIM2, PIM1, RET, SGK1, BRAF
11anti-apoptosisGO:00691629.2PIM2, PIK3CA, SH3GLB1, RELA, SERPINB2, NAIP
12axon guidanceGO:00741127.3NCAM1, NCK1, RELN, CNTN6, SEMA3C, SEMA3A
13cell-cell signalingGO:00726726.5KLF10, SEMA3B, VIPR2, NAMPT, BMP2, BMP3
14induction of apoptosisGO:00691724.6KLF10, PDCD5, BOK, BNIP3, BNIP3L, USP7
15epidermal growth factor receptor signaling pathwayGO:00717322.7PIK3CA, PIK3R1, PIK3C2A, REPS2, RAF1, CLTC
16positive regulation of cell migrationGO:03033522.5RET, VEGFA, MYLK, BMP2, KDR, LEF1
17transcription initiation from RNA polymerase II promoterGO:00636722.4NCOR1, NCOR2, RBL1, SERPINE1, VDR, MYC
18fibroblast growth factor receptor signaling pathwayGO:00854322.2PIK3CA, PIK3R1, BRAF, RAF1, CHUK, YWHAB
19insulin receptor signaling pathwayGO:00828622.0PIK3CB, PIK3CA, PIK3R3, PIK3R2, PIK3R1, PIK3C2A
20transforming growth factor beta receptor signaling pathwayGO:00717921.5KLF10, NCOR1, NCOR2, RBL1, SERPINE1, MYC
21positive regulation of gene expressionGO:01062821.5PIAS3, NCOA3, RELB, KIT, SFRP4, BRAF
22response to estradiol stimulusGO:03235521.3NCOA1, SFRP4, GC, SERPINA1, BRCA2, VDR
23cell surface receptor signaling pathwayGO:00716621.3BSG, MYD88, BIRC2, BIRC3, KHDRBS1, BDKRB2
24response to lipopolysaccharideGO:03249621.0CNR1, CNR2, SELE, SELP, SERPINA1, BDKRB1
25heart developmentGO:00750720.7PCNA, VCAM1, VCAN, BMP2, RAF1, PAM
26positive regulation of NF-kappaB transcription factor activityGO:05109219.4RELA, MYD88, CLU, BCL10, CHUK, UBC
27MyD88-dependent toll-like receptor signaling pathwayGO:00275519.3RELA, MYD88, CHUK, UBC, UBE2V1, ATF2
28toll-like receptor signaling pathwayGO:00222419.2RELA, MYD88, BCL10, CHUK, UBC, UBE2V1
29toll-like receptor 4 signaling pathwayGO:03414219.1RELA, MYD88, CHUK, UBC, UBE2V1, ATF2
30elevation of cytosolic calcium ion concentrationGO:00720419.0LPAR1, LPAR2, LPAR3, UTS2R, BDKRB1, BDKRB2
31positive regulation of angiogenesisGO:04576618.8BTG1, SERPINE1, VEGFA, UTS2R, KDR, CHI3L1
32positive regulation of ERK1 and ERK2 cascadeGO:07037418.7SERPINF2, BRAF, BMP2, BMP4, KDR, CHI3L1
33toll-like receptor 1 signaling pathwayGO:03413018.7RELA, MYD88, CHUK, UBC, UBE2V1, ATF2
34toll-like receptor 2 signaling pathwayGO:03413418.7RELA, MYD88, CHUK, UBC, UBE2V1, ATF2
35positive regulation of MAPK cascadeGO:04341018.7CNTF, KIT, LPAR1, LPAR2, LPAR3, LIF
36negative regulation of neuron apoptotic processGO:04352418.4CNTF, SET, NAIP, BRAF, LIG4, PARK7
37response to ethanolGO:04547118.4CNR1, BGLAP, BCL2, LCT, BAK1, S100A8
38platelet degranulationGO:00257618.2VWF, SELP, SERPINF2, SERPINA1, SERPINE1, VEGFA
39response to glucocorticoid stimulusGO:05138418.1SFRP4, SERPINF1, SERPINE1, BGLAP, PAM, CEBPA
40toll-like receptor 3 signaling pathwayGO:03413818.1RELA, CHUK, UBC, ATF2, JUN, CD14
41MyD88-independent toll-like receptor signaling pathwayGO:00275618.1RELA, CHUK, UBC, ATF2, JUN, CDK1
42leukocyte migrationGO:05090018.0PIK3CB, PIK3CA, PIK3R2, PIK3R1, SELP, BSG
43cellular response to mechanical stimulusGO:07126017.4BNIP3, MYD88, BCL10, CHEK1, BAD, BAK1
44positive regulation of protein kinase B signaling cascadeGO:05189717.4PIK3R5, PIK3CG, CHI3L1, MTDH, MTOR, MST1R
45response to woundingGO:00961116.9VWF, RAC1, PAX6, ITGB4, FN1, FGF7
46positive regulation of peptidyl-tyrosine phosphorylationGO:05073116.9RELN, KITLG, VTN, VEGFA, LIF, PAK2
47positive regulation of cell divisionGO:05178116.8BTC, VEGFA, VEGFC, YBX1, FIGF, FGF1
48induction of apoptosis by intracellular signalsGO:00862916.3BNIP3, MYC, BID, CLU, BCL2, BCL2L1
49positive regulation of phosphatidylinositol 3-kinase cascadeGO:01406816.2RELN, CNTF, KIT, SELP, KDR, JAK2
50MAPK cascadeGO:00016516.2RET, MYC, RASGRP3, RAF1, SCG2, YWHAB

Molecular functions related to prostate cancer according to GeneDecks:

(show all 21)
idNameGO IDScoreTop Affiliating Genes
1protein bindingGO:005515207.1ZNF652, PIK3CB, PIK3CD, PIAS2, PIK3CA, PIAS3
2ATP bindingGO:00552461.4PIK3CB, PIK3CD, PIM2, PIK3CA, PIK3C2B, PIP5K1A
3sequence-specific DNA binding transcription factor activityGO:00370046.4ZNF155, KLF10, KLF5, KLF6, REL, RELA
4protein homodimerization activityGO:04280340.7SH3GLB1, KIT, VWF, RCHY1, SERPINF2, VEGFA
5sequence-specific DNA bindingGO:04356535.4NANOG, VDR, MYC, RAG1, RARA, RARB
6protein kinase bindingGO:01990128.9RELA, KIF11, VIM, RAD9A, LIPE, ZFP36
7transcription factor bindingGO:00813428.6PIM1, RELA, RB1, RBL1, NBN, NAB2
8identical protein bindingGO:04280228.4PIK3AP1, SH3GLB1, RELA, SFRP1, PCNA, VIM
9receptor bindingGO:00510227.3NCK1, RCHY1, SERPINE1, LPL, VCP, BMP2
10enzyme bindingGO:01989926.8PIAS3, PIAS1, NCOA1, PCBP2, BTG1, BRCA1
11protein heterodimerization activityGO:04698226.3BRAF, VEGFA, BOK, BNIP3, BNIP3L, MYC
12protein serine/threonine kinase activityGO:00467425.0PIM2, PIK3CA, PIK3CG, PIM1, SGK1, BRAF
13growth factor activityGO:00808324.3CNTF, KITLG, BTC, VEGFA, VEGFC, BMP10
14chromatin bindingGO:00368223.6NCOA1, NCOA2, NCOA3, RELA, PCGF2, LMO2
15transcription regulatory region DNA bindingGO:04421223.2RFX6, NCOR1, RELA, BRCA1, ZFHX3, PAX2
16transcription coactivator activityGO:00371322.8PIAS2, PIAS1, NCOA1, NCOA2, NCOA3, NCOA4
17protein kinase activityGO:00467221.8PIK3CG, PIK3C3, BRAF, RAF1, LIMK1, PAK4
18cytokine activityGO:00512521.2CNTF, KITLG, NAMPT, VEGFA, BMP10, BMP2
19ubiquitin protein ligase bindingGO:03162520.1PIAS2, PIAS4, RELA, PCBP2, RB1, BRCA1
20protein tyrosine kinase activityGO:00471318.7RET, KIT, LMTK2, BMX, KDR, BCR
21androgen receptor bindingGO:05068115.8PIAS2, PIAS1, NCOA1, NCOA3, NCOA4, RB1

Sources for Prostate Cancer

about this section
2CDC
11FMA
18HMDB
19ICD9CM
20KEGG
24MeSH
25MGI
27NCIt
28NDF-RT
31NINDS
32Novoseek
33OMIM
35PubMed
36QIAGEN
43UMLS
Browse MalaCards: 1-9 | A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z